Does DOSTARLIMAB Cause Neuropathy peripheral? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Neuropathy peripheral have been filed in association with DOSTARLIMAB (Jemperli). This represents 2.9% of all adverse event reports for DOSTARLIMAB.
26
Reports of Neuropathy peripheral with DOSTARLIMAB
2.9%
of all DOSTARLIMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Neuropathy peripheral From DOSTARLIMAB?
Of the 26 reports, 2 (7.7%) resulted in death, 4 (15.4%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
Yes, Neuropathy peripheral is listed as a known adverse reaction in the official FDA drug label for DOSTARLIMAB.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Condition aggravated (27)
Dyspnoea (26)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which DOSTARLIMAB Alternatives Have Lower Neuropathy peripheral Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN